SAM CHUN DANG PHARM CO. LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 000250 for the last quarter is 52.38 B KRW, and it's 4.57% lower compared to the previous quarter. The net income of Q3 24 is -1.11 B KRW.